Parmalat posts profit as strategy takes shape
Parmalat's profit before interest and tax rose 18.4 per cent in the first two months of 2006 to € 45 million, with predictions that net debt would remain stable over the year.
Archives for March 30, 2006
Forward-looking Forbes Medi-Tech racks up R&D losses
Forbes Medi-Tech is expecting future growth for its branded nutraceutical business to be borne of its milestone deal with leading UK retailer Tesco, yet is philosophical that it will continue reporting losses until one of its ventures bears...
Danish saw palmetto withdrawal due to safety
The Danish food safety authorities have withdrawn saw palmetto products from the market pending an assessment of their safety.
Antioxidants may not reduce pregnancy complications
Vitamins C and E might not reduce the risk of pre-eclampsia in high-risk women, and may even lead to under-weight babies, says a new study.
Tea's brain health benefit link gets more support
Both green and black tea could protect against age-related diseases like Alzheimer's, says a new study, adding yet more support to the benefits of tea extract on brain health.
Herbal ingredient gives incontinence hope
UroLogic, herbal ingredient launching in products in the US this month, could provide a new natural means of managing incontinence, after being shown to significantly improve the symptoms of urinary incontinence and overactive bladder in a human...
Natraceutical moves to patent cocoa fibre process
Spain's Natraceutical Group has developed a new alkalization process to make its soluble cocoa fiber suitable for use in functional milk products, an area it has identified as offering strong opportunities in the functional sector.
Raspberries - the berries are booming
Raspberries possess about 50 per cent higher antioxidant activity than strawberries, and storage or processing into jams does not remove the valuable compounds, as growing consumer awareness of health benefits drive sales.
ADM files suit to protect soy isoflavone rights
The battle surrounding the technology rights for the production of soy isoflavones has been refired as Archer Daniels Midland files a lawsuit against a US firm for infringing patent rights.